Angiotensin II is associated with activation of NF- B- mediated genes and downregulation of PPARs

[PDF] [Full Text] [Abstract] , February 1, 2008; 294 (2): R438-R447. Am J Physiol Regulatory Integrative Comp Physiol L. M. Bivol, R. K. Berge and B. M. Iversen hypertension Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip [PDF] [Full Text] [Abstract] , February 15, 2008; 102 (3): 283-294. Circ. Res. S. Z. Duan, M. G. Usher and R. M. Mortensen Peroxisome Proliferator-Activated Receptor-{gamma}-Mediated Effects in the Vasculature [PDF] [Full Text] [Abstract] , March 1, 2008; 31 (3): 502-508. Eur. Respir. J. A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen and A. M. Schols Peroxisome proliferator-activated receptors: a therapeutic target in COPD? [PDF] [Full Text] [Abstract] , May 1, 2008; 28 (5): 863-870. Arterioscler. Thromb. Vasc. Biol. Kurata, S. Kihara, I. Shimomura and T. Funahashi K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, T. Hibuse, H. Nishizawa, M. Nishida, A. Hiuge, A. of PPAR-{alpha} Adiponectin Protects Against Angiotensin II-Induced Cardiac Fibrosis Through Activation [PDF] [Full Text] [Abstract] , June 10, 2008; 0 (2008): hcn066v1-hcn066. QJM A. Bakhai Adipokines--targeting a root cause of cardiometabolic risk

[1]  R. Evans,et al.  A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .

[2]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[3]  P. Libby,et al.  PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells , 1999 .

[4]  Wan-Wan Lin,et al.  Pyrimidinoceptor potentiation of macrophage PGE2 release involved in the induction of nitric oxide synthase , 2000, British journal of pharmacology.

[5]  W. Koenig,et al.  Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.

[6]  I. Adcock,et al.  Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆ , 1997 .

[7]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[8]  C. Glass,et al.  Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .

[9]  F. Luft,et al.  Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Frank J. Gonzalez,et al.  Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1* , 1999, The Journal of Biological Chemistry.

[11]  Amyj . Williams,et al.  NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation , 1994, The Journal of experimental medicine.

[12]  J. Satta.  Expansion and rupture of abdominal aortic aneurysms. , 1998, Annales chirurgiae et gynaecologiae.

[13]  R. Alexander.  Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.

[14]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[15]  M. Runge,et al.  Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor , 2004, Molecular and Cellular Biochemistry.

[16]  E. Nabel,et al.  Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells , 1993, Molecular and cellular biology.

[17]  H. Ledebur,et al.  Transcriptional Regulation of the Intercellular Adhesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells , 1995, The Journal of Biological Chemistry.

[18]  M. Runge,et al.  Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. , 1999, Circulation research.

[19]  J. Scholes,et al.  The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. , 1994, Journal of vascular surgery.

[20]  J. Blanco,et al.  Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-κB and AP-1 in the Kidney : Role of AT1 and AT2 Receptors , 2001 .

[21]  S. Keidar.  Angiotensin, LDL peroxidation and atherosclerosis. , 1998, Life sciences.

[22]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[23]  Jen-kun Lin,et al.  (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .

[24]  T. Willson,et al.  Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. , 2000, The Journal of clinical investigation.

[25]  D. Altshuler,et al.  The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.

[26]  Xueliang Du,et al.  Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? , 1999 .

[27]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[28]  M. Jaye,et al.  PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.

[29]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[30]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[31]  M. Halks-Miller,et al.  Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. , 2001, The American journal of pathology.

[32]  P. Carmeliet,et al.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation , 1997, Nature Genetics.

[33]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[34]  MichaelAviram,et al.  Angiotensin II–Modified LDL Is Taken Up by Macrophages Via the Scavenger Receptor, Leading to Cellular Cholesterol Accumulation , 1996 .

[35]  D. Weiss,et al.  Angiotensin II and atherosclerosis. , 2001, The American journal of cardiology.

[36]  W. Wahli,et al.  The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.

[37]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.